HRP20030907B1 - Farmaceutska kompozicija na bazi makrolida za lokalnu upotrebu u oftalmologiji - Google Patents

Farmaceutska kompozicija na bazi makrolida za lokalnu upotrebu u oftalmologiji

Info

Publication number
HRP20030907B1
HRP20030907B1 HR20030907A HRP20030907A HRP20030907B1 HR P20030907 B1 HRP20030907 B1 HR P20030907B1 HR 20030907 A HR20030907 A HR 20030907A HR P20030907 A HRP20030907 A HR P20030907A HR P20030907 B1 HRP20030907 B1 HR P20030907B1
Authority
HR
Croatia
Prior art keywords
pharmaceutical composition
macrolid
ophthalmology
local use
based pharmaceutical
Prior art date
Application number
HR20030907A
Other languages
English (en)
Croatian (hr)
Inventor
Luyckx Jacques
Pilotaz Fr�d�ric
Original Assignee
Laboratoires Thea
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Thea filed Critical Laboratoires Thea
Publication of HRP20030907A2 publication Critical patent/HRP20030907A2/hr
Publication of HRP20030907B1 publication Critical patent/HRP20030907B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
HR20030907A 2001-04-12 2002-04-11 Farmaceutska kompozicija na bazi makrolida za lokalnu upotrebu u oftalmologiji HRP20030907B1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0105114A FR2823441B1 (fr) 2001-04-12 2001-04-12 Composition pharmaceutique a base de macrolides pour application locale en ophtalmologie et son procede de preparation
PCT/FR2002/001263 WO2002083178A1 (fr) 2001-04-12 2002-04-11 Composition pharmaceutique a base de macrolides pour application locale en ophtalmologie

Publications (2)

Publication Number Publication Date
HRP20030907A2 HRP20030907A2 (en) 2004-02-29
HRP20030907B1 true HRP20030907B1 (hr) 2010-04-30

Family

ID=8862340

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20030907A HRP20030907B1 (hr) 2001-04-12 2002-04-11 Farmaceutska kompozicija na bazi makrolida za lokalnu upotrebu u oftalmologiji

Country Status (30)

Country Link
US (1) US7064109B2 (cs)
EP (1) EP1377316B1 (cs)
JP (2) JP4558275B2 (cs)
KR (1) KR100835002B1 (cs)
CN (1) CN1496270B (cs)
AR (1) AR034033A1 (cs)
AT (1) ATE397460T1 (cs)
BR (1) BRPI0208367B8 (cs)
CA (1) CA2443728C (cs)
CY (1) CY1108302T1 (cs)
CZ (1) CZ300213B6 (cs)
DE (1) DE60226962D1 (cs)
DK (1) DK1377316T3 (cs)
EA (1) EA008088B1 (cs)
EG (1) EG23169A (cs)
ES (1) ES2307754T3 (cs)
FR (1) FR2823441B1 (cs)
HR (1) HRP20030907B1 (cs)
HU (1) HU230459B1 (cs)
MA (1) MA27005A1 (cs)
MX (1) MXPA03009349A (cs)
OA (1) OA12462A (cs)
PA (1) PA8543401A1 (cs)
PE (1) PE20021082A1 (cs)
PL (1) PL204403B1 (cs)
PT (1) PT1377316E (cs)
SI (1) SI1377316T1 (cs)
TN (1) TNSN03091A1 (cs)
WO (1) WO2002083178A1 (cs)
ZA (1) ZA200307718B (cs)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602004017477D1 (de) * 2004-11-09 2008-12-11 Novagali Pharma Sa Öl-in-Wasser-Emulsion mit niedriger Konzentration des kationischen Mittels und positivem Zetapotential
FR2884716B1 (fr) * 2005-04-22 2009-08-21 Thea Sa Lab Utilisation de l'azithromycine pour la fabrication d'un medicament destine au traitement des infections oculaires
JPWO2007074904A1 (ja) * 2005-12-28 2009-06-04 わかもと製薬株式会社 水性医薬組成物
CA2679448A1 (en) * 2007-02-28 2008-09-04 Aciex, Inc. Methods and compositions for normalizing meibomian gland secretions
US20100158821A1 (en) * 2008-12-22 2010-06-24 Eastman Chemical Company Antimicrobial agents, compositions and products containing the same, and methods of using the compositions and products
CN101780105B (zh) * 2009-01-20 2011-09-28 沈阳兴齐制药有限公司 小牛血去蛋白提取物的滴眼液
EP2228058A1 (en) 2009-03-04 2010-09-15 Novagali Pharma S.A. Anionic oil-in-water emulsion containing prostaglandins and uses thereof
US8106111B2 (en) * 2009-05-15 2012-01-31 Eastman Chemical Company Antimicrobial effect of cycloaliphatic diol antimicrobial agents in coating compositions
EP2389939A1 (en) 2010-05-28 2011-11-30 Novagali Pharma S.A. Use of prostaglandins F2alpha and analogues for the healing of corneal and conjunctival lesions
EP2394636B1 (en) * 2010-05-28 2014-03-19 Novagali Pharma S.A. Method for treating retinal conditions using an intraocular tamponade
US9044508B2 (en) * 2013-03-15 2015-06-02 Insite Vision Corporation Concentrated aqueous azalide formulations
CN109689027A (zh) * 2016-06-29 2019-04-26 奥德纳米有限公司 甘油三酯耳用制剂及其用途
PT3266446T (pt) * 2016-07-07 2019-01-30 Salvat Lab Sa Composição oftálmica compreendendo óleo de rícino e triglicérido de cadeia média
CN115475248A (zh) * 2021-06-16 2022-12-16 云南拜奥泰克生物技术有限责任公司 一种新型药用甘油三酯溶剂及其应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1152644A (en) * 1966-07-01 1969-05-21 Abbott Lab Stable Solutions of Erythromycin Free Base
EP0925789A1 (en) * 1997-12-02 1999-06-30 Pfizer Products Inc. Topical azithromycin compositions for the treatment of ocular infections
WO2000057866A2 (en) * 1999-03-31 2000-10-05 Insite Vision Incorporated Use of azalide antibiotics for the topical treatment or prevention of ocular infections

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6468328A (en) * 1987-09-09 1989-03-14 Suntory Ltd Anticorneoulcerative
JP2563336B2 (ja) * 1987-06-01 1996-12-11 エーザイ株式会社 角膜透過促進点眼剤
FR2746035B1 (fr) * 1996-03-15 1998-06-12 Microparticules de gel composite susceptibles d'etre utilisees comme vecteur(s) de principe(s) actif(s), l'un de leurs procedes de preparation et leurs applications
JP2000159659A (ja) * 1998-11-30 2000-06-13 Kazuo Tsubota 眼科用人工涙液

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1152644A (en) * 1966-07-01 1969-05-21 Abbott Lab Stable Solutions of Erythromycin Free Base
EP0925789A1 (en) * 1997-12-02 1999-06-30 Pfizer Products Inc. Topical azithromycin compositions for the treatment of ocular infections
WO2000057866A2 (en) * 1999-03-31 2000-10-05 Insite Vision Incorporated Use of azalide antibiotics for the topical treatment or prevention of ocular infections

Also Published As

Publication number Publication date
OA12462A (fr) 2006-06-24
PT1377316E (pt) 2008-09-15
TNSN03091A1 (fr) 2005-12-23
BR0208367A (pt) 2004-03-09
ATE397460T1 (de) 2008-06-15
PE20021082A1 (es) 2002-12-18
SI1377316T1 (sl) 2008-10-31
HUP0303864A2 (hu) 2004-03-01
HRP20030907A2 (en) 2004-02-29
PA8543401A1 (es) 2003-01-24
HU230459B1 (hu) 2016-07-28
EA008088B1 (ru) 2007-02-27
BR0208367B1 (pt) 2013-11-12
CA2443728C (fr) 2011-01-04
FR2823441A1 (fr) 2002-10-18
JP2004526763A (ja) 2004-09-02
DE60226962D1 (de) 2008-07-17
CA2443728A1 (fr) 2002-10-24
EG23169A (en) 2004-06-30
CN1496270A (zh) 2004-05-12
ZA200307718B (en) 2004-09-02
HK1065708A1 (zh) 2005-03-04
CY1108302T1 (el) 2014-02-12
PL204403B1 (pl) 2010-01-29
JP4558275B2 (ja) 2010-10-06
MA27005A1 (fr) 2004-12-20
US7064109B2 (en) 2006-06-20
ES2307754T3 (es) 2008-12-01
KR20030088466A (ko) 2003-11-19
EP1377316A1 (fr) 2004-01-07
FR2823441B1 (fr) 2004-09-10
WO2002083178A1 (fr) 2002-10-24
DK1377316T3 (da) 2008-09-22
JP2010043109A (ja) 2010-02-25
JP5170780B2 (ja) 2013-03-27
AR034033A1 (es) 2004-01-21
CN1496270B (zh) 2010-05-26
EA200301108A1 (ru) 2004-04-29
BRPI0208367B8 (pt) 2021-05-25
US20040197340A1 (en) 2004-10-07
PL363538A1 (en) 2004-11-29
CZ300213B6 (cs) 2009-03-18
HUP0303864A3 (en) 2012-07-30
EP1377316B1 (fr) 2008-06-04
MXPA03009349A (es) 2004-11-12
KR100835002B1 (ko) 2008-06-09
CZ20032771A3 (cs) 2004-01-14

Similar Documents

Publication Publication Date Title
HRP20030907B1 (hr) Farmaceutska kompozicija na bazi makrolida za lokalnu upotrebu u oftalmologiji
ES2191048T3 (es) Derivados de oxazolidinona y compuestos farmaceuticos que los contienen.
ES2123654T3 (es) Carbapenems que contienen un grupo fenilo substituido con carboxi, procesos para su preparacion, productos intermedios y uso como antibioticos.
AR037517A1 (es) Derivados de naftiridinas, un proceso para su preparacion, composicion farmaceutica y el uso de los mismos para la preparacion de un medicamento para el tratamiento de una enfermedad inflamatoria
GT198900008A (es) Derivados de quinolina, quinazolina y cinolina.
DK0828724T3 (da) 5-oxygenerede diaryl-2-(5H)-furanoner som COX-2-inhibitorer
BR0108395A (pt) Derivados de pirrolopirimidinona, processos de preparação e uso
BR0209320A (pt) ésteres de uridina farmaceuticamente ativos
AR044200A1 (es) Composicion de fondaparinux sodico de alta pureza ,un procedimiento de preparacion de esta composicion y composiciones farmaceuticas que la contienen como principio activo
CY1108882T1 (el) Φαρμακευτικο μεσο για την αγωγη ιικων δερματικων και νεοπλασιακων παθησεων
DE60123277D1 (de) Makrolidantibiotika
DK1392329T3 (da) Anvendelse af sulodexid til behandling af inflammatorisk tarmsygdom
ES2063146T3 (es) Composiciones farmaceuticas que contienen acido n-(3,4-dimetoxicinamoil)-antranilico.
BR0206935A (pt) Composto, formulação farmacêutica, uso de um composto, método de tratamento e/ou profilaxia de condições associadas com a inibição da glicogênio sintase quinase-3, e, processo para a preparação de um composto
AR019496A1 (es) Azalidas de 13 miembros, composiciones farmaceuticas, uso en la preparacion de medicamentos y preparacion de los mismos
BRPI0413413A (pt) feniloxazolidinonas de piperidino substituìdo tendo atividade antimicrobiana com eficácia in vivo melhorada
BR0006301A (pt) Macrólidos antibacterianos e pró-cinéticos
BRPI0411702A (pt) uso de ácido hialurÈnico para preparar composições para o tratamento de aftas da cavidade oral
BG101570A (bg) Производни на еритромицин а 9-0-оксим, притежаващи антибиотична активност
BRPI0506493A (pt) combinações terapêuticas
AR032553A1 (es) Derivados de alfa-amino-n-hidroxi-acetamida.
ATE437636T1 (de) Pharmazeutische zusammensetzungen die ein dibenzocyclooctanlignanderivat enthalten zur vorbeugung und behandlung neurodegenerativer erkrankungen
ES2150404T3 (es) Composiciones farmaceuticas de tizoxanida y nitozoxanida.
MA26735A1 (fr) Formes cristallines nouvelles d'un antibiotique macrolide, procede pour leur preparation et compositions pharmaceutiques les contenant
BR0017340A (pt) Tratamento de trauma e outras indicações

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20190325

Year of fee payment: 18

ODRP Renewal fee for the maintenance of a patent

Payment date: 20200319

Year of fee payment: 19

ODRP Renewal fee for the maintenance of a patent

Payment date: 20210318

Year of fee payment: 20

PB20 Patent expired after termination of 20 years

Effective date: 20220411